Yes, thank, Tom, that was a good summary. Look, Dan, it is the case that we have got good performance. I think we've also got good business momentum here. And I think we're constructively looking to the second-half with that business momentum as well as the performance, and saying we're positive on the outlook for the rest of the year. And just commenting a moment on the business momentum, and I said it in my prepared remarks, 25% of the business in private markets, ESG, and wealth, and another 25% in liquid alternatives. So, our overall positioning is very advantaged, certainly relative to other periods where really everything was growth-oriented, and the liquid alternatives segment was not really expressing itself. So, I think you're seeing, in 2022, the liquid alternatives concentration -- our concentration of liquid alternatives really adding to our earnings flow. The other thing that I think we've talked in the prior call, but I'll revisit it again, is value equities. So, when you look at our [long-only] [Ph] book, in general, we have a value orientation. And as we've all seen, value has outperformed significantly this year. And clients, as they think about their allocations, we think they will increasingly look to more value-oriented strategies, which is going to benefit a number of our affiliates, including AQR, but also Yacktman, River Road, Tweedy, and Veritas. So, we're very constructive on the portion of our business that's long-only equities as well. And then lastly, I think, just to make a finer point, the impact of our capital allocation strategy is notable this year. Clearly, investment in new affiliates are contributing, but also the excess capital that we've returned through repurchases, having done already about 5% year-to-date. All of those things taken together, I think, are the reasons why we've made the comments on the second-half.